Healthlead PCL (HL.BK) Stock Price

Healthlead PCL Price

CLOSED
4.48
​
Market closed

Over the last 8 years Healthlead PCL grew revenue by 15.6% annually, reaching 2.23 B THB. Earnings per share have grown at 112.3% per year over the last 7 years. For Healthlead PCL, the net margin of 3.5% is down versus 6.6% a few years ago. At today's price the dividend yield works out to roughly 3.79%. The payout ratio is around 58% of earnings. The dividend has grown at 2.0% per year over the past 3 years. The consensus 12-month price target for Healthlead PCL is 12.24 THB, about 173.2% above where the stock trades today. Of 8 analysts, 0 rate the stock a buy — an overall Sell consensus.

Healthlead PCL stock price

Access this data via the Eulerpool API

Healthlead PCL business model & stock analysis

Healthlead PCL is a holding company, which engages in the provision of pharmacy businesses, distribution of medicine, medical supplies, cosmeceuticals, dietary supplements, medical equipment, and various health products. The company is headquartered in Nonthaburi, Nonthaburi and currently employs 484 full-time employees. The company went IPO on 2021-12-03. The principal businesses of the Company and its subsidiaries include pharmacy business distributing medicines, medical supplies, cosmeceuticals, supplements, medical devices, and other healthcare products as well as in business regarding invention business, developing, importing, and distributing healthcare products. The company operates pharmacies under four brands namely Icare, Pharmax, vitaminclub, and Super Drug. The firm sells more than 10,000 stock-keeping units (SKUs) of medical supplies, cosmeceuticals, dietary supplements, medical equipment, and healthcare products via these pharmacies in response to customers’ various needs. Its pharmacies feature medicines, dietary supplements, medical equipment, household utensils, external healthcare products, and consumer goods. Its PRIME brand is a dietary supplement product, which includes PRIME Hibiki Collagen Pure and PRIME Acerola Cherry Extract 1200 MG.

Frequently asked questions about Healthlead PCL

Analysts currently set an average price target of 12.24 THB for the Healthlead PCL stock (median: 12.24 THB), implying +173.2 % versus the latest price. The consensus is based on 8 analyst ratings.

8 analysts currently rate the Healthlead PCL stock: 0 recommend buying, 3 holding and 5 selling. For 2026, analysts expect Healthlead PCL to generate revenue of 2.37 B THB and earnings per share of 0.42 THB.

Converted at the current exchange rate, the Healthlead PCL share trades at 0.12 EUR (4.48 THB).

The expected revenue of Healthlead PCL is 2.37 B THB. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Healthlead PCL is 111.52 M THB. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Healthlead PCL is currently 10.69. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Healthlead PCL stock.

The price-to-sales ratio (P/S) of Healthlead PCL is currently 0.50. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Healthlead PCL stock.

The Eulerpool Quality Score for Healthlead PCL is 2/10.

The ISIN of Healthlead PCL is THA598010009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Healthlead PCL is HL.BK. The ticker symbol is used to trade Healthlead PCL shares on the stock exchange.

Fair ValueTerminal
4.39 THB
Over-/UndervaluationTerminal
Fairly valued
Industry
Consumer Staples Distribution & Retail
Number of shares
Employees
Revenue per Employee
4.61 M THB
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Thailand
Currency
THB
Initial public offering
Dec 3, 2021
ISIN
THA598010009
Cusip
Y306F6112
Market capitalization
1.22 B THBSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
10.93
P/S
P/Se
0.50
EV/EBIT
20.41
P/B Ratio
1.26
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.05 %
Dividend
Dividend yield
3.79 %
Est. Dividend Yield
3.87 %
Payout Ratio
58.13 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
4 years
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
10.00 %
Last updated Oct 10, 2026, 9:40 PM

Healthlead PCL Peer Group

Healthlead PCL FIGI

HL:TB · BBG0135XHR15